Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant

Retrovirology

Volumn 2, Issue , 2005, Pages

  Zhang, Hong ^a,b   Hoffmann, Federico ^b   He, Jun ^a,b   He, Xiang ^a,b   Kankasa, Chipepo ^c   Ruprecht, Ruth ^d   West, John T ^a,b   Orti, Guillermo ^b   Wood, Charles ^a,b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA   (United States)

^c University Teaching Hospital   (Zambia)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; NEUTRALIZING ANTIBODY; VIRUS PROTEIN; CHEMOKINE RECEPTOR CCR5; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMINO ACID SEQUENCE; ARTICLE; CORRELATION ANALYSIS; GENE MUTATION; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INFANT; INFECTION RESISTANCE; MOLECULAR EVOLUTION; MONOPHYLY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN PROCESSING; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; VERTICAL TRANSMISSION; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS STRAIN; VIRUS TRANSMISSION; ZAMBIA; BLOOD; CLASSIFICATION; DISEASE COURSE; DISEASE TRANSMISSION; ENVELOPE GENE; GENETICS; IMMUNOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SERODIAGNOSIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CHILD, PRESCHOOL; DISEASE PROGRESSION; EVOLUTION, MOLECULAR; GENES, ENV; HIV ANTIBODIES; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; NEUTRALIZATION TESTS; RECEPTORS, CCR5; VIRUS REPLICATION;

EID: 27944461010     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-2-67     Document Type: Article

References (66)

1. Essex M: State of the HIV pandemic. J Hum Virol 1998, 1(7):427-429.
2. Janssens W, Buve A, Nkengasong JN: The puzzle of HIV-1 subtypes in Africa. AIDS 1997, 11(6):705-712.
3. Rodenburg CM, Li Y, Trask SA, Chen Y, Decker J, Robertson DL, Kalish ML, Shaw GM, Allen S, Hahn BH, Gao F: Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses 2001, 17(2):161-168.
4. Luzuriaga K, Sullivan JL: Pediatric HIV-1 infection: advances and remaining challenges. AIDS Rev 2002, 4(1):21-26.
5. Edgeworth RL, Ugen KE: Immunopathological factors for vertical transmission of HIV-1. Pathobiology 2000, 68(2):53-67.
6. Arroyo MA, Tien H, Pagan M, Swanstrom R, Hillyer GV, Cadilla CL, Melendez-Guerrero LM: Virologic risk factors for vertical transmission of HIV type 1 in Puerto Rico. AIDS Res Hum Retroviruses 2002, 18(6):447-460.
7. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C, Lew JF: Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999, 341(6):394-402.
8. John GC, Nduati RW, Mbori-Ngacha DA, Richardson BA, Panteleeff D, Mwatha A, Overbaugh J, Bwayo J, Ndinya-Achola JO, Kreiss JK: Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001, 183(2):206-212.
9. Dickover RE, Garratty EM, Plaeger S, Bryson YJ: Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol 2001, 75(5):2194-2203.
10. Wolinsky SM, Wike CM, Korber BT, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, Munoz JL: Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992, 255(5048):1134-1137.
11. Scarlatti G, Leitner T, Halapi E, Wahlberg J, Marchisio P, Clerici-Schoeller MA, Wigzell H, Fenyo EM, Albert J, Uhlen M, Rossi P: Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci U S A 1993, 90(5):1721-1725.
12. Ahmad N, Baroudy BM, Baker RC, Chappey C: Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 1995, 69(2):1001-1012.
13. Pasquier C, Cayrou C, Blancher A, Tourne-Petheil C, Berrebi A, Tricoire J, Puel J, Izopet J: Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeflciency virus type 1. J Virol 1998, 72(11):8493-8501.
14. Lamers SL, Sleasman JW, She JX, Barrie KA, Pomeroy SM, Barrett DJ, Goodenow MM: Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission. J Clin Invest 1994, 93(1):380-390.
15. Chakraborty R: HIV-1 infection in children: a clinical and immunologic overview. Curr HIV Res 2005, 3(1):31-41.
16. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR: Identification of envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991, 253(5015):71-74.
17. Fouchier RA, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H: Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992, 66(5):3183-3187.
18. de Jong JJ, Goudsmit J, Keulen W, Klaver B, Krone W, Tersmette M, de Ronde A: Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 1992, 66(2):757-765.
19. Milich L, Margolin B, Swanstrom R: V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J Virol 1993, 67(9):5623-5634.
20. Stamatatos L, Cheng-Mayer C: Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J Virol 1993, 67(9):5635-5639.
21. Richman DD, Bozzette SA: The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994, 169(5):968-974.
22. Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P: The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med 1996, 2(11):1244-1247.
23. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR: Change in coreceptor use coreceptor use correlates with disease progression in HIV-1--infected individuals. J Exp Med 1997, 185(4):621-628.
24. Hayman A, Moss T, Arnold C, Naylor-Adamson L, Balfe P: Disease progression in heterosexual patients infected with closely related subtype B strains of HIV type 1 with differing coreceptor usage properties. AIDS Res Hum Retroviruses 2004, 20(4):365-371.
25. Nabatov AA, Pollakis G, Linnemann T, Kliphius A, Chalaby MI, Paxton WA: Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies. J Virol 2004, 78(1):524-530.
26. Oelrichs RB, Shrestha IL, Anderson DA, Deacon NJ: The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity. J Virol 2000, 74(3):1149-1157.
27. Zhang H, Orti G, Du Q, He J, Kankasa C, Bhat G, Wood C: Phylogenetic and phenotypic analysis of HIV type 1 env gp120 in cases of subtype C mother-to-child transmission. AIDS Res Hum Retroviruses 2002, 18(18):1415-1423.
28. Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M, Denham SA, Heil ML, Kasolo F, Musonda R, Hahn BH, Shaw GM, Korber BT, Allen S, Hunter E: Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004, 303(5666):2019-2022.
29. Verhofstede C, Demecheleer E, De Cabooter N, Gaillard P, Mwanyumba F, Claeys P, Chohan V, Mandaliya K, Temmerman M, Plum J: Diversity of the human immunodeficiency virus type 1 (HIV-1) env sequence after vertical transmission in mother-child pairs infected with HIV-1 subtype A. J Virol 2003, 77(5):3050-3057.
30. Blanche S, Rouzioux C, Moscato ML, Veber F, Mayaux MJ, Jacomet C, Tricoire J, Deville A, Vial M, Firtion G, Crepy AD, Douard D, Robin M, Courptin C, Ciraru-Vigneron N, Diest F, Griscelli C: A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med 1989, 320(25):1643-1648.
31. Blanche S, Tardieu M, Duliege A, Rouzioux C, Le Deist F, Fukunaga K, Caniglia M, Jacomet C, Messiah A, Griscelli C: Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child 1990, 144(11):1210-1215.
32. Mayaux MJ, Burgard M, Teglas JP, Cottalorda J, Krivine A, Simon F, Puel J, Tamalet C, Dormont D, Masquelier B, Doussin A, Rouzioux C, Blanche S: Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. Jama 1996, 275(8):606-610.
33. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI: Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 1999, 73(12):10489-10502.
34. Delwart EL, Pan H, Sheppard HW, Wolpert D, Neumann AU, Korber B, Mullins JI: Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J Virol 1997, 71(10):7498-7508.
35. Hutto C, Zhou Y, He J, Geffin R, Hill M, Scott W, Wood C: Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses. J Virol 1996, 70(6):3589-3598.
36. Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, Yu XF: Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc Natl Acad Sci U S A 1998, 95(21):12568-12573.
37. Nowak MA, Bangham CR: Population dynamics of immune responses to persistent viruses. Science 1996, 272(5258):74-79.
38. Salvatori F, Masiero S, Giaquinto C, Wade CM, Brown AJ, Chieco-Bianchi L, De Rossi A: Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. J Virol 1997, 71(6):4694-4706.
39. Joos B, Trkola A, Fischer M, Kuster H, Rusert P, Leemann C, Boni J, Oxenius A, Price DA, Phillips RE, Wong JK, Hirschel B, Weber R, Gunthard HF: Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions. J Virol 2005, 79(14):9026-9037.
40. Troyer RM, Collins KR, Abraha A, Fraundorf E, Moore DM, Krizan RW, Toossi Z, Colebunders RL, Jensen MA, Mullins JI, Vanham G, Arts EJ: Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression. J Virol 2005, 79(14):9006-9018.
41. Abebe A, Demissie D, Goudsmit J, Brouwer M, Kuiken CL, Pollakis G, Schuitemaker H, Fontanet AL, Rinke de Wit TF: HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS 1999, 13(11):1305-1311.
42. Cilliers T, Nhlapo J, Coetzer M, Orlovic D, Ketas T, Olson WC, Moore JP, Trkola A, Morris L: The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C. J Virol 2003, 77(7):4449-4456.
43. Johnston ER, Zijenah LS, Mutetwa S, Kantor R, Kittinunvorakoon C, Katzenstein DA: High Frequency of Syncytium-Inducing and CXCR4-Tropic Virus among Human Immunodeficiency Virus Type 1 Subtype C-Infected Patients Receiving Antiretroviral Treatment. J Virol 2003, 77(13):7682-7688.
44. Pollakis G, Abebe A, Kliphuis A, Chalaby MIM, Bakker M, Mengistu Y, Brouwer M, Goudsmit J, Schuitemaker H, Paxton WA: Phenotypic and Genotypic Comparisons of CCR5- and CXCR4-Tropic Human Immunodeficiency Virus Type 1 Biological Clones Isolated from Subtype C-Infected Individuals. J Virol 2004, 78(6):2841-2852.
45. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V: Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 2001, 58:19-42.
46. Richman DD, Wrin T, Little SJ, Petropoulos CJ: Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A 2003, 100(7):4144-4149.
47. Arendrup M, Nielsen C, Hansen JE, Pedersen C, Mathiesen L, Nielsen JO: Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J Acquir Immune Defic Syndr 1992, 5(3):303-307.
48. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM: Antibody neutralization and escape by HIV-1. Nature 2003, 422(6929):307-312.
49. Khouri YF, McIntosh K, Cavacini L, Posner M, Pagano M, Tuomala R, Marasco WA: Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest 1995, 95(2):732-737.
50. Ganeshan S, Dickover RE, Korber BT, Bryson YJ, Wolinsky SM: Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J Virol 1997, 71(1):663-677.
51. Halapi E, Leitner T, Jansson M, Scarlatti G, Orlandi P, Plebani A, Romiti L, Albert J, Wigzell H, Rossi P: Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants. Aids 1997, 11(14):1709-1717.
52. Bradney AP, Scheer S, Crawford JM, Buchbinder SP, Montefiori DC: Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors. J Infect Dis 1999, 179(5):1264-1267.
53. Lathey JL, Pratt RD, Spector SA: Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1. J Infect Dis 1997, 175(1):231-232.
54. McGrath KM, Hoffman NG, Resch W, Nelson JA, Swanstrom R: Using HIV-1 sequence variability to explore virus biology. Virus Res 2001, 76(2):137-160.
55. Mantina H, Kankasa C, Klaskala W, Brayfield B, Campbell J, Du Q, Bhat G, Kasolo F, Mitchell C, Wood C: Vertical transmission of Kaposi's sarcoma-associated herpesvirus. Int J Cancer 2001, 94(5):749-752.
56. Cheng-Mayer C, Shioda T, Levy JA: Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol 1991, 65(12):6931-6941.
57. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG: The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997, 25(24):4876-4882.
58. Ronquist F, Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 2003, 19(12):1572-1574.
59. Jobb G, von Haeseler A, Strimmer K: TREEFINDER: a powerful graphical analysis environment for molecular phylogenetics. BMC Evol Biol 2004, 4(1):18.
60. Swofford DL: PAUP* Phylogenetic Analysis using parsimony and other methods. In., Version 4.0 beta edn. Sunderland, MA: Sinauer Associates; 1998.
61. Posada D, Crandall KA: MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14(9):817-818.
62. Kumar S, Tamura K, Nei M: MEGA: Molecular Evolutionary Genetics Analysis. In., 1.01 edn. University Park, PA 16802: The Pennsylvania State University; 1993.
63. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R: DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 2003, 19(18):2496-2497.
64. Kosakovsky Pond SL, Frost SDW: Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 2005:bti320.
65. Yang Z: PAML: a program package for phylogenetic analysis by mammum likelihood. Comput Appl Biosci 1997, 13(5):555-556.
66. Nielsen R, Yang Z: Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 1998, 148(3):929-936.